Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Farris Maryanne Maunsell is VP, Chief Accounting Officer at Haemonetics. OQRO lists 11 transactions filed with the SEC under this name, the latest on Nov 13, 2026, each linked to the official Form 4.
VP, Chief Accounting Officer
Disclosures on record
11
Companies involved
1
Farris Maryanne Maunsell has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
Farris Maryanne Maunsell reported 0 open-market purchases and 1 sale since 2026; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $101K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
HaemoneticsHAE
11 disclosures · May 2026 – Nov 2026 · 1 sold
Nov 11, 2026Sold~$101Kdisclosed Nov 13
DetailsOfficial recordNov 11, 2026645disclosed Nov 13
DetailsOfficial recordNov 11, 2026433disclosed Nov 13
DetailsOfficial recordNov 11, 20261,068disclosed Nov 13
DetailsOfficial recordNov 11, 20261,068disclosed Nov 13
DetailsOfficial recordNov 11, 2026645disclosed Nov 13
DetailsOfficial recordNov 11, 2026433disclosed Nov 13
DetailsOfficial recordNov 11, 20261,724disclosed Nov 13
DetailsOfficial recordJun 5, 2026259disclosed Jun 8
DetailsOfficial recordMay 15, 20262,220disclosed May 19
DetailsOfficial recordMay 15, 2026197disclosed May 19
DetailsOfficial recordAs of the latest filing on , Farris Maryanne Maunsell reported holding 5,828 shares of Haemonetics (HAE), worth about $707K at the last close of $121 (Nov 16, 2026). In the last 12 months, Farris Maryanne Maunsell sold $101K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Haemonetics HAE | 5,828 | 5,828 direct | $121 | $707K | Nov 11, 2026 |
Is this Farris Maryanne Maunsell’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Farris Maryanne Maunsell reported 0 open-market purchases and 1 sale here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Nov 11, 2026, Farris Maryanne Maunsell reported holding 5,828 shares of Haemonetics (HAE). At the last close of $121 on Nov 16, 2026, that is about $707K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Farris Maryanne Maunsell reported 1 open-market sale worth $101K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Farris Maryanne Maunsell has no open-market purchase on record since 2026. Sales in 1 of the 1 years since 2026.
In SEC filings since 2026: no open-market purchase is on record; the latest open-market sale is from 2026.
Haemonetics (HAE), from 2026 to 2026: 0 purchases and 1 sale.